Skip to main content
. 2019 Mar 7;48(1):0300060519826848. doi: 10.1177/0300060519826848

Figure 2.

Figure 2.

Body weight and systolic blood pressure of normal and metabolic syndrome rats treated with or without AST. (a) Bodyweight and (b) systolic blood pressure in normal control rats, metabolic syndrome rats, and metabolic syndrome rats treated with AST 0.5 or 2.0 mg/kg.

AST: astragaloside IV, NC: normal control. Data shown as mean ± SEM (n = 12). *P < 0.05 vs. NC group.